COR-INSIGHT: Optimizing Cardiovascular and Cardiopulmonary Outcomes with AI-Driven Multiplexed Indications Using COR ECG Wearable

Launched by PEERBRIDGE HEALTH, INC · Jan 1, 2025

Keywords

ClinConnect Summary

The COR-INSIGHT trial is a clinical study designed to evaluate the effectiveness of Peerbridge COR ambulatory ECG wearables, COR 1.0 and COR 2.0 ("CORMDX"). These devices integrate advanced AI technologies, including CardioMIND and CardioQSync, to accurately detect a broad spectrum of cardiovascular and cardiopulmonary conditions. By offering multiplexed diagnostics via direct-from-ECG analysis, the trial seeks to validate an alternative to traditional diagnostic modalities such as imaging, catheter-based techniques, and biochemical assays.

COR-INSIGHT study is validating a comprehensive, ...

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Age ≥ 18 years
• • Able and eligible to wear a Holter monitor
• Exclusion Criteria:
• • 1. Receiving any mechanical (respiratory or circulatory) or renal support therapy at Screening or during Visit #1.
• • 2. Any other conditions that in the opinion of the investigators are likely to prevent compliance with the study protocol or pose a safety concern if the subject participates in the study.
• • 3. Poor tolerance, susceptibility to severe skin reactions from ECG adhesive.